Anticancer activity of phenoxazines produced by bovine erythrocytes on colon cancer cells

Oncology Reports

Volumn 23, Issue 6, 2010, Pages 1517-1522

  Nakachi, Takeshi ^a   Tabuchi, Takafumi ^a   Takasaki, Akira ^b   Arai, Sadao ^b   Miyazawa, Keisuke ^b   Tomoda, Akio ^b  

^a Ibaraki pref   (Japan)

^b TOKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Anticancer activity; Colon cancer cells; Phenoxazines

Indexed keywords

2 AMINO 4,4ALPHA DIHYDRO 4ALPHA,7 DIMETHYL 3H PHENOXAZINE 3 ONE; 2 AMINOPHENOXAZINE 3 ONE; ANTINEOPLASTIC AGENT; HEMOGLOBIN; PHENOXAZINE DERIVATIVE; UNCLASSIFIED DRUG; 2-AMINO-4,4ALPHA-DIHYDRO-4ALPHA,7-DIMETHYL-3H-PHENOXAZINE-3-ONE; 3-AMINOPHENOXAZONE; OXAZINE DERIVATIVE;

ABSORPTION SPECTROSCOPY; ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER CELL DESTRUCTION; CANCER INHIBITION; CARBON NUCLEAR MAGNETIC RESONANCE; CARCINOMA CELL; COLON CARCINOMA; CONCENTRATION RESPONSE; COW; DRUG IDENTIFICATION; DRUG STRUCTURE; DRUG SYNTHESIS; ERYTHROCYTE; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REACTION TIME; ANIMAL; BOVINAE; CELL PROLIFERATION; COLONIC NEOPLASMS; DRUG EFFECTS; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; THIN LAYER CHROMATOGRAPHY; TUMOR CELL CULTURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CATTLE; CELL PROLIFERATION; CHROMATOGRAPHY, THIN LAYER; COLONIC NEOPLASMS; ERYTHROCYTES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; OXAZINES; TUMOR CELLS, CULTURED;

EID: 77951713348     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or_00000790     Document Type: Article

References (23)

1. Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, Maroun JA, Ackland SP, Locker PK, Pirotta N, Elfring GL and Miller LL: Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med 343: 905-914, 2000.
2. Hoff PM, Ansari R, Batist G, Cox J, Kocha W, Kuperminc M, Maroun J, Walde D, Weaver C, Harrison E, Burger HU, Osterwalder B, Wong AO and Wong R: Comparison of oral capecitabine vs intravenous fluorouracil plus leucovorin as first-line treatment in 605 patients with metastatic colorectal cancer: results of a randomized phase III study. J Clin Oncol 19: 2282-2292, 2001. (Pubitemid 32366981)
3. Dulabh K, Monga MD and O'Connell MJ: Surgical adjuvant therapy for colorectal cancer: current approaches and future directions. Anal Surg Oncol 13: 1021-1034, 2006. (Pubitemid 44337961)
4. Mori H, Honda K, Ishida R and Tomoda A: Antitumor activity of 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one against Meth A tumor transplanted into BALB/c mice. Anti-Cancer Drugs 11: 653-765, 2000.
5. Shimamoto T, Tomoda A, Ishida R and Ohyashiki K: Antitumor effects of a novel phenoxazine derivative on human leukemia cell lines in vitro and in vivo. Clin Cancer Res 7: 704-708, 2001. (Pubitemid 32707997)
6. Miyano-Kurosaki N, Kurosaki K, Hayashi M, Takaku H, Hayafune M, Shrato K, Kasuga T, Endo T and Tomoda A: 2-Aminophenoxazine-3-one suppresses the growth of mouse malignant melanoma B16 cells transplanted into C57BL/6Cr Slc mice. Biol Pharm Bull 29: 2197-2201, 2006. (Pubitemid 44690942)
7. Kasuga T, Tabuchi T, Shirato K, Imaizumu K and Tomoda A: Caspase-independent cell death revealed in human gastric cancer cell lines, MKN45 and KATO III treated with phenoxazine derivatives. Oncol Rep 17: 409-415, 2007.
8. Shirato K, Imaizumi K, Abe A and Tomoda A: Phenoxazine derivatives, 2-amino-4,4α-dihydro-4α,7-dimethyl-3H-phenoxazine-3-one and 2-aminophenoxazine-3-one-induced apoptosis through a caspase-independent mechanism in human neuroblastoma cell line NB-1 cells. Biol Pharm Bull 30: 331-336, 2007. (Pubitemid 46255375)
9. Shirato K, Imaizumi K, Miyazawa K, Takasaki A, Mizuguchi J, Che X-F, Akiyama S and Tomoda A: Apoptosis induction preceded by mitochondrial depolarization in multiple myeloma cell line U266 by 2-aminophenoxazine-3-one. Biol Pharm Bull 31: 62-67, 2008.
10. Hollstein U: Actinomycin: chemistry and mechanism of action. Chem Rev 74: 625-652, 1974.
11. Tomoda A, Arai S, Ishida R, Shimamoto T and Ohyashiki K: An improved method for the rapid preparation of 2-amino-4,4α-dihydro-4α,7- dimethyl-3H-phenoxazine-3-one, a novel antitumor agent. Bioorg Med Chem Lett 11: 1057-1058, 2001. (Pubitemid 32327967)
12. Shimizu S, Suzuki M, Miyazawa K, Yokoyama T, Ohyashki K, Kiyazaki K and Tomoda A: Phenoxazine compounds produced by the reactions with bovine hemoglobin show antimicrobial activity against non-tuberculosis mycobacteria. Tohoku J Exp Med 203: 47-52, 2004. (Pubitemid 38832654)
13. Chibber BAK, Balasubramanian A and Viswanatha T: Binding of actinomycin chromophore analogues to DNA. Can J Biochem 51: 204-217, 1972.
14. Hoerlein U, Risse KH and Wirth W: Pharmacological comparison of phenoxazine and phenothiazine compounds. Med Chem: Abhandl Med Chem Forschungsstaetten Farbenfabriken Bayer 7: 79-98, 1963.
15. Ward HW: Actinomycin D for Wilms's tumor. Br Med J 1: 42, 1973.
16. Tomoda A, Hamashima H, Arisawa M, Kikuchi T, Tezuka Y and Koshimura S: Phenoxazinone synthesis by human hemoglobin. Biochim Biophys Acta 1117: 3036-3140, 1992.
17. Nagasawa HT, Gutmann HR and Morgan MA: The oxidation of o-aminophenols by cytochrome c and cytochrome oxidase. II. Synthesis and identification of oxidation products. J Biol Chem 234: 1600-1604, 1959.
18. Barry CE, Nayer PG and Begley TP: Phenoxazinone synthase: enzymatic catalysis of an amonophenol oxidative cascade. J Am Chem Soc 110: 3333-3334, 1988.
19. Katz E and Weissbach H: Biosynthesis of the actinomycin chromophore; Enzymatic conversion of 4-methyl-3-hydroxyanthranilic acid to actinocin. J Biol Chem 237: 882-886, 1962.
20. Tomoda A, Yamaguchi J, Kojima H, Amemiya H and Yoneyama Y: Mechanism of o-aminophenol metabolism in human erythrocytes. FEBS Lett 196: 44-48, 1986.
21. Eckert KG and Eyer P: Differences in the reactions of isomeric ortho- and para-aminophenols with hemoglobin. Biochem Pharmacol 32: 1019-1027, 1983.
22. Kohno K, Miyake M, Sano O, Tanaka-Kataoka M, Yamamoto S, Koya-Miyata S, Arai N, Mitsukiyo F, Watanabe H, Ushio S, Iwaki K and Fukuda S: Anti-inflammatory and immunomodulatory properties of 2-amino-3H-phenoxazin-3- one. Biol Pharm Bull 31: 938-1945, 2008.
23. Kato S, Shirato K, Imaizumi K, Toyota H, Mizuguchi J, Odawara M, Che X-F, Akiyama S, Abe A and Tomoda A: Anticancer effects of phenoxazine derivatives combined with tumor necrosis factor-related apoptosis-inducing ligand on pancreatic cancer cell lines, KLM-1 and MIA-PaCa-2. Oncol Rep 15: 843-848, 2006.